Dry Needling Vs Transcutaneous Electrical Nerve Stimulation in Management of Myofascial Pain Dysfunction Syndrome

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-50
SponsorCairo University

About this trial

Myofascial pain dysfunction syndrome (MPDS) is the most common form of temporomandibular disorders. Because of the multifactorial nature of the problem, its management is still not definite. This randomized clinical trial aimed to assess the efficacy of transcutaneous electrical nerve stimulation over dry needling for management of such condition.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients complaining of pain in muscles of mastication lasting for three months or more.

Presence of trigger points in the temporalis, masseter or lateral pterygoid muscle identified by clinical examination and palpation.

Average pain severity of at least 4 on a 10-point scale

Pain in pre-auricular area, or in the ear during rest or function

Disqualifiers

No previous tempro-mandibular joint (TMJ) surgical intervention

Patients with neurological disorders, coagulopathy, vascular disease autoimmune disease (systemic lupus, rheumatoid arthritis), fibromyalgia

Pregnancy

Current opioid use

Trial design

Design model

Parallel

Treatments tested in this trial

  • TENS

    Procedure/Surgery

    Non-pharmacological method which is widely used by medical and paramedical professionals for the management of acute and chronic pain using electric pulse generator, lead wires and electrodes.

  • Dry Needle

    Procedure/Surgery

    Invasive procedure where a fine needle or acupuncture needle is inserted into the skin and muscle.

Treatment groups

26 Participants
are divided into 2 treatment groups
Group A: Transcutaneous electrical nerve stimulationExperimental treatment 1 intervention
Group B: Dry NeedlingActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Pain

Using visual analogue scale (VAS) from (1-10) where 1 is the least pain and 10 is the maximum pain

Time frame
From enrollment to the end of treatment at 6 months

Secondary outcomes

1

Muscle stiffness

using Electromyography to measure muscle response or electrical activity in response to a nerve stimulation of the muscle (volt)

Time frame
From enrollment to the end of treatment at 6 months
2

Limitation in mouth openinig

Measuring muscle opening using digital caliber (Micrometer)

Time frame
From enrollment to the end of treatment at 6 months
3

Sleeping disorder

Assessing sleeping disorder through Yes or No questionnaire

Time frame
From enrollment to the end of treatment at 6 months
4

Anxiety

Assessing anxiety through Yes or No questionnaire

Time frame
From enrollment to the end of treatment at 6 months

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: